Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of single-dose dexmedetomidine and non-sedation on postoperative cognitive dysfunction in elderly patients undergoing hip and knee surgery
TCTR20260604002Phase 4Recruiting
- Sponsor
- N/A
- Start
- May 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of dexmedetomidine in post-operative cognitive decline (POCD), sponsored by N/A. Started May 2026; status: recruiting.
02
Drugs
dexmedetomidine
03
Conditions
post-operative cognitive decline (POCD)
Beyond the preview
Go deeper on TCTR20260604002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20260604002.